Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Shares Outstanding (2020 - 2025)

Cresco Labs' Shares Outstanding history spans 6 years, with the latest figure at $500000.0 for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $500000.0; the TTM value through Dec 2025 reached $500000.0, changed 0.0%, while the annual FY2025 figure was $500000.0, 0.0% changed from the prior year.
  • Shares Outstanding reached $343.2 million in Q4 2025 per CRLBF's latest filing, up from $2000.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $343.2 million in Q4 2025 to a low of $2000.0 in Q4 2024.
  • Average Shares Outstanding over 5 years is $166.4 million, with a median of $207.0 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 1497.24% in 2023, then crashed 99.84% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $63.9 million in 2021, then crashed by 68.56% to $20.1 million in 2022, then surged by 1497.24% to $320.8 million in 2023, then plummeted by 99.84% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Shares Outstanding are $500000.0 (Q4 2025), $500000.0 (Q4 2024), and $320.8 million (Q4 2023).